Inhibition of p53 function diminishes androgen receptor-mediated signaling in prostate cancer cell lines
Tóm tắt
Từ khóa
Tài liệu tham khảo
Agus DB, Cordon-Cardo C, Fox W, Drobnjak M, Koff A, Golde DW and Scher HI . (1999). J. Natl. Cancer Inst., 91, 1869–1876.
Aprikian AG, Sarkis AS, Fair WR, Zhang ZF, Fuks Z and Cordon-Cardo C . (1994). J. Urol., 151, 1276–1280.
Asschert JG, De Vries EG, De Jong S, Withoff S and Vellenga E . (1999). Int. J. Cancer, 81, 236–242.
Burchardt M, Burchardt T, Shabsigh A, Ghafar M, Chen MW, Anastasiadis A, de la Taille A, Kiss A and Buttyan R . (2001). Prostate, 48, 225–230.
Caleffi M, Teague MW, Jensen RA, Vnencak-Jones CL, Dupont WD and Parl FF . (1994). Cancer, 73, 2147–2155.
Chen T, Wang LH and Farrar WL . (2000). Cancer Res., 60, 2132–2135.
Coursen JD, Bennett WP, Khan MA, Forrester K, Pietenpol JA and Harris CC . (1997). Mol. Carcinogen., 19, 191–203.
Culig Z, Hobisch A, Cronauer MV, Cato ACB, Hittmair A, Radmayr C, Eberle J, Bartsch G and Klocker H . (1993). Mol. Endocrinol., 7, 1541–1550.
Cronauer MV, Eder IE, Hittmair A, Sierek G, Hobisch A, Culig Z, Thurnher M, Bartsch G and Klocker H . (1997). In Vitro Cell Dev. Biol. Anim., 33, 742–744.
Cronauer MV, Nessler-Menardi C, Klocker H, Maly K, Hobisch A, Bartsch G and Culig Z . (2000). Br. J. Cancer, 82, 39–45.
Eastham JA, Stapleton AM, Gousse AE, Timme TL, Yang G, Slawin KM, Wheeler TM, Scardino PT and Thompson TC . (1995). Clin. Cancer Res., 1, 1111–1118.
Freedland SJ, Pantuk AJ, Paik SH, Zisman A, Graeber TG, Eisenberg D, McBride WH, Nguyen D, Tso C-L and Belldegrun AS . (2003). Prostate, 55, 299–307.
Grossman SR, Perez M, Kung AL, Joseph M, Mansur C, Xiao ZX, Kumar S and Howley PM . (1998). Mol. Cell, 2, 405–415.
Gurova KV, Roklin OW, Krivokrysenko VI, Chumakov PM, Cohen MB, Feinstein E and Gudkov AV . (2002). Oncogene, 2, 153–157.
Heisler LE, Evangelou A, Lew AM, Trachtenberg J, Elsholtz HP and Brown TJ . (1997). Mol. Cell. Endocrinol., 126, 59–73.
Hobisch A, Eder IE, Putz T, Horninger W, Bartsch G, Klocker H and Culig Z . (1998). Cancer Res., 58, 4640–4645.
Isaacs WB, Carter BS and Ewing CM . (1991). Cancer Res., 51, 4716–4720.
Jacobberger JW, Sramkoski RM, Zhang D, Zumstein LA, Doerksen LD, Merritt JA, Wright SA and Shults KE . (1999). Cytometry, 38, 201–213.
Komarov PG, Komarova EA, Kondratov RV, Christov-Tselkov K, Coon JS, Chernov MV and Gudkov AV . (1999). Science, 285, 1733–1737.
Komarova EA, Neznanov N, Komarov PG, Chernov MV, Wang K and Gudkov A . (2003). J. Biol. Chem., 278, 15465–15468.
Kremenetskaya OS, Logacheva NP, Baryshnikov AY, Chumakov PM and Kopnin BP . (1997). Oncol. Res., 9, 155–166.
Lee YG, Korenchuk S, Lehr J, Whitney S, Vessela R and Pienta KJ . (2001). In Vivo, 15, 157–162.
Lin H-Y, Shih AI, Davis FB, Tang H-Y, Martino LJ, Bennett JA and Davis PJ . (2002a). J. Urol., 168, 748–755.
Makri D, Schulz WA, Grimm M-O, Clasen S, Bojar H and Schmitz-Dräger BJ . (1998). Int. J. Oncol., 12, 621–628.
Marth C, Müller-Holzner E, Greiter E, Cronauer MV, Zeimet AG, Doppler W, Eibl B, Hynes NE and Daxenbichler G . (1990). Cancer Res., 50, 7037–7041.
Meyers FJ, Gumerlock PH, Chi SG, Borchers H, Deitch AD and deVere White RW . (1998). Cancer, 83, 2534–2539.
Navone NM, Troncoso P, Pisters LL, Goodrow TL, Palmer JL, Nichols WW, von Eschenbach AC and Conti CJ . (1993). J. Natl. Cancer Inst., 85, 1657–1669.
Nesslinger NE, Shi X-B and deVere White RW . (2003). Cancer Res., 63, 2228–2233.
Osman I, Drobnjak M, Fazzari M, Ferrara J, Scher HI and Cordon-Cardo C . (1999). Clin. Cancer Res., 5, 2082–2088.
Patel BJ, Pantuck AJ, Zisman A, Tsui KH, Paik SH, Caliliw R, Sheriff S, Wu L, deKernion JB, Tso CL and Belldegrun AS . (2000). J. Urol., 164, 1420–1425.
Peehl DM . (1994). Atlas of Human Tumor Cell Lines, Hay RJ, Park J-G, Gazdar A (eds) Academic Press: London, pp. 387–411.
Pocard M, Chevillard S, Villaudy J, Poupon MF, Dutrillaux B and Remvikos Y . (1996). Oncogene, 12, 875–882.
Rubin SJ, Hallahan DE, Ashman CR, Brachman DG, Beckett MA, Virudachalam S, Yandell DW and Weichselbaum RR . (1991). J. Surg. Oncol., 46, 31–36.
Runnebaum IB, Tong XW, Mobus VJ, Kieback DG, Rosenthal HE and Kreienberg R . (1994). FEBS Lett., 353, 29–32.
Schumacher G, Bruckheimer EM, Beham AW, Honda T, Brisbay S, Roth JA, Logothetis C and McDonnell TJ . (2001). Int. J. Cancer, 94, 159–166.
Shenk JL, Fisher CJ, Chen SY, Zhou XF, Tillman K and Shemshedini L . (2001). J. Biol. Chem., 276, 38472–38479.
Sinisi AA, Chieffi P, Pasquali D, Kisslinger A, Staibano S, Bellastella A and Tramontano D . (2002). In Vitro Cell Dev. Anim., 38, 165–172.
Sramkoski RM, Pretlow TG, Giaconia JM, Pretlow TP, Schwartz S, Sy MS, Marengo SR, Rhim JS, Zhang D and Jacobberger JW . (1999). In Vitro Cell Dev. Biol. Anim., 35, 403–409.
Srivastava S, Katayose D, Tong YA, Craig CR, McLeod DG, Moul JW, Cowan KH and Seth P . (1995). Urology, 46, 843–848.
Steinhoff C, Prior A, Reichmann G, Seifert HH and Schulz WA . (2002). Int. J. Oncol., 21, 1033–1040.
Tepper CG, Boucher DL, Ryan PE, Ma A-H, Xia L, Lee L-F, Pretlow TG and Kung H-J . (2002). Cancer Res., 62, 6606–6614.
Yu CL, Driggers P, Barrera-Hernandez G, Nunez SB, Segars JH and Cheng S . (1997a). Biochem. Biophys. Res. Commun., 239, 520–617.